Document Detail


Immune surveillance of the maternal/fetal interface: controversies and implications.
MedLine Citation:
PMID:  20304670     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
How the fetal 'allograft' avoids rejection during pregnancy remains a major unresolved immunological paradox. Recent work has suggested that fetomaternal tolerance is in fact maintained by a number of redundant mechanisms, but their relative importance has remained poorly defined. In this paper, I discuss an emerging controversy regarding the ability of maternal T cells to mediate fetal rejection at a time when they appear to be ignorant of fetal and placental antigens. This paradox within a paradox highlights two major research directions in the field of reproductive immunology that, when ultimately reconciled, promise to give significant insight into mechanisms of impaired fertility and compromised fetal and maternal health.
Authors:
Adrian Erlebacher
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2010-03-19
Journal Detail:
Title:  Trends in endocrinology and metabolism: TEM     Volume:  21     ISSN:  1879-3061     ISO Abbreviation:  Trends Endocrinol. Metab.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-05     Completed Date:  2010-10-15     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  9001516     Medline TA:  Trends Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  428-34     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Affiliation:
New York University School of Medicine, New York, NY, USA. Adrian.Erlebacher@nyumc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Female
Immune Tolerance
Immunologic Surveillance
Male
Maternal-Fetal Exchange / immunology*
Mice
Placenta / cytology,  immunology*
Pregnancy / immunology*
Grant Support
ID/Acronym/Agency:
R01 AI062980-01A1/AI/NIAID NIH HHS; R01-AI062980/AI/NIAID NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Targeting immune suppressing myeloid-derived suppressor cells in oncology.
Next Document:  Is prolactin the cardinal calciotropic maternal hormone?